ArticleProceedings of the National Academy of Sciences of the United States of America2025

A SynB1-conjugated antibody cocktail crosses the blood-brain barrier to produce a therapeutic effect on rabies.

Zeheng Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.